Patients with DR of any type had significantly more type 1 diabetes (p < 0.001), higher glycated hemoglobin (p < 0.001), longer duration of diabetes (p < 0.001), more insulin treatment (p < 0.001), and fewer oral antidiabetics (p < 0.001). This evidence concerns the gene INS and type 1 diabetes mellitus.